Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue:
Revenues	$ 52,904	$ 39,986	$ 31,432
Operating costs and expenses:
Research and development	206,922	111,340	106,879
Acquired in-process research and development	24,208	42,992	75,301
Selling, general and administrative	196,856	116,179	103,557
Intangible amortization	4,140	4,053	3,941
Loss (gain) on contingent consideration	9,198	0	(11,090)
Total operating costs and expenses	454,355	284,504	290,825
Loss from operations	(401,451)	(244,518)	(259,393)
(Loss) gain on derivative liabilities	(300)	6,600	(36,792)
Loss on marketable investments	(15,013)	0	0
Loss on debt extinguishment	(6,695)	(51,939)	(27,810)
(Loss) gain on foreign currency exchange	(973)	812	(330)
Scilex Notes principal increase	(28,000)	0	0
Interest expense, net	(10,224)	(20,157)	(35,048)
Other income gain (loss)	128	(1,378)	(203)
Loss before income tax	(462,528)	(310,580)	(359,576)
Income tax benefit	(33,516)	(2,014)	(473)
Loss on equity method investments	(126)	(5,844)	(3,909)
Net loss	(429,138)	(314,410)	(363,012)
Net loss attributable to noncontrolling interests	(813)	(15,949)	(70,944)
Net loss attributable to Sorrento	$ (428,325)	$ (298,461)	$ (292,068)
Net loss per share - basic per share attributable to Sorrento	$ (1.45)	$ (1.30)	$ (2.20)
Net loss per share - diluted per share attributable to Sorrento	$ (1.45)	$ (1.30)	$ (2.35)
Weighted-average shares outstanding during period - basic shares attributable to Sorrento (in shares)	294,774	229,823	132,732
Weighted-average shares outstanding during period - diluted shares attributable to Sorrento (in shares)	294,774	229,823	140,514
Product
Revenue:
Revenues	$ 28,735	$ 26,628	$ 21,974
Operating costs and expenses:
Cost of product sold and services	3,851	2,149	5,933
Service
Revenue:
Revenues	24,169	13,358	9,458
Operating costs and expenses:
Cost of product sold and services	$ 9,180	$ 7,791	$ 6,304